Neurocycle Therapeutics raises €450K Seed round
13 February 2019· Zurich, Switzerland· health, drug_discovery, biotech, small_molecule_drug, b2b, deep_hardware
The funding was a Grant (prize money) from NIH SBIR to study next-generation treatment of Dravet Syndrome, and other support for seed-stage development.
Investors
LeadNIH
Also participating
Venture KickVenturelab
About Neurocycle Therapeutics
Stage
Seed
Headquarters
Zurich, Switzerland
Founded
2015
Team Size
6–20
Sectors
healthdrug_discoverybiotechsmall_molecule_drugb2bdeep_hardware